GLP-1

Characterization of the glucagon-like peptide-1 receptor signaling pathway in pancreatic beta-cells: glucose-dependent insulinotropic mechanism^[1]

This study characterized the signaling cascade downstream of GLP-1 receptor activation in isolated rat pancreatic islets and INS-1 beta-cell cultures. GLP-1(7-36) amide at physiological concentrations (0.1-10 nM) activated adenylyl cyclase through Gs-protein coupling, increasing intracellular cAMP and activating PKA within 60 seconds of exposure. Importantly, the insulin secretory response was strictly glucose-dependent -- GLP-1 at these concentrations did not stimulate insulin release in the absence of glucose above 5.5 mM, confirming the glucose-gating of its insulinotropic action. The authors identified KATP channel closure and L-type calcium channel activation as downstream effectors linking elevated cAMP to insulin granule exocytosis.

Last verified: 2026-04-03

GLP-1 suppresses glucagon secretion from pancreatic alpha-cells via paracrine somatostatin signaling^[2]

The mechanism by which GLP-1 suppresses glucagon secretion was investigated using isolated perfused rat pancreas and sorted alpha-cell preparations. Direct application of GLP-1 to purified alpha-cells did not suppress glucagon secretion despite confirmed GLP-1R expression, leading the investigators to test a paracrine hypothesis. Blocking somatostatin signaling with cysteamine or a somatostatin receptor 2 antagonist abolished GLP-1-induced glucagon suppression, demonstrating an indirect mechanism through delta-cell somatostatin release. These findings resolved the longstanding question of GLP-1's direct versus indirect mechanism at the alpha-cell and have implications for understanding incretin action in metabolic research.

Last verified: 2026-04-03